Society

Spain, France and the Netherlands receive an experimental Japanese vaccine against hantavirus

1 min
Image of the evacuation of passengers suspected of hantavirus infection.Elton Monteiro / Xinhua News / Europa Press

Spain, France and the Netherlands will receive the first doses of a hantavirus vaccine to treat patients or conduct clinical trials, the European Commission announced this Thursday. The European Medicines Agency (EMA) has chosen favipiravir, an experimental Japanese vaccine.